EUVIMEDEUVIMED entdecken
Open Access

Lipopolysaccharide promotes bladder cancer immunosuppression by disrupting the Tfh/Tfr balance through TLR4 signaling

Bo Peng, Yan Wang, Haochen Li, Changshui Zhuang, Rijian Guan, Haopeng Zhang, Lijun Wan

American Journal of Translational Research · 2026 · 18 (7) · 5612-5622

DOI: 10.62347/cqyq8046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Translational Research, 2026. Verfasst von Bo Peng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital Quzhou, Zhejiang, China. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To investigate the role of lipopolysaccharide (LPS)-mediated toll-like receptor 4 (TLR4) signaling in modulating the tumor immune microenvironment, particularly the follicular helper T cell (Tfh)/follicular regulatory T cell (Tfr) equilibrium, in bladder cancer. METHODS: MBT-2 and MB49 cells were treated with LPS. TLR4 was knocked down using lentiviral short hairpin RNA. Cell proliferation, migration, and invasion were assessed by methylthiazolyldiphenyl-tetrazolium bromide, scratch, and Transwell assays. A subcutaneous xenograft model in C57BL/6 and C3H/He mice was established. Tfh/Tfr cells in spleens were analyzed by flow cytometry. TLR4 and related cytokine expression were measured by quantitative polymerase chain reaction and western blot. RESULTS: . These pro-tumor effects were reversed by TLR4 knockdown. Furthermore, LPS skewed the Tfh/Tfr ratio in favor of Tfh cells. At the cytokine level, LPS increased the production of interleukin-21 but decreased the levels of forkhead box P3, interleukin-10, and transforming growth factor-beta. All these immunologic alterations were also abolished upon TLR4 knockdown. CONCLUSION: LPS exacerbated bladder cancer progression by activating TLR4 signaling. This disrupts the Tfh/Tfr balance and creates an immunosuppressive niche. Targeting this axis may represent a novel therapeutic strategy.

Schlagwörter

Stichwörter der Autor:innen

Bladder cancerT follicular helper cellsT follicular regulatory cellsimmunosuppressionlipopolysaccharidetoll-like receptor 4

Autor:innen und Institutionen

  • Reproductive Medicine Center, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital Quzhou, Zhejiang, China.
  • Department of Laboratory Animal Sciences, Tianjin Medical University Tianjin, China.
  • Tianjin International Travel Health Care Center Tianjin, China.
  • Department of Urology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital Quzhou, Zhejiang, China.
  • School of Medical Technology, Tianjin University of Traditional Chinese Medicine Tianjin, China.

Zitieren

APA

Peng, B., Wang, Y., Li, H., Zhuang, C., Guan, R., Zhang, H., & Wan, L. (2026). Lipopolysaccharide promotes bladder cancer immunosuppression by disrupting the Tfh/Tfr balance through TLR4 signaling. American Journal of Translational Research, 18(7), 5612-5622. https://doi.org/10.62347/cqyq8046

Vancouver

Peng B, Wang Y, Li H, Zhuang C, Guan R, Zhang H, et al. Lipopolysaccharide promotes bladder cancer immunosuppression by disrupting the Tfh/Tfr balance through TLR4 signaling. American Journal of Translational Research. 2026;18(7):5612-5622. doi:10.62347/cqyq8046

BibTeX
@article{Peng2026,
  author = {Peng, Bo and Wang, Yan and Li, Haochen and Zhuang, Changshui and Guan, Rijian and Zhang, Haopeng and Wan, Lijun},
  title = {Lipopolysaccharide promotes bladder cancer immunosuppression by disrupting the Tfh/Tfr balance through TLR4 signaling},
  journal = {American Journal of Translational Research},
  year = {2026},
  volume = {18},
  number = {7},
  pages = {5612--5622},
  doi = {10.62347/cqyq8046}
}
Kostenlos starten →